IL135727A0 - Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom - Google Patents
Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atomInfo
- Publication number
- IL135727A0 IL135727A0 IL13572798A IL13572798A IL135727A0 IL 135727 A0 IL135727 A0 IL 135727A0 IL 13572798 A IL13572798 A IL 13572798A IL 13572798 A IL13572798 A IL 13572798A IL 135727 A0 IL135727 A0 IL 135727A0
- Authority
- IL
- Israel
- Prior art keywords
- nitrogen atom
- heterocyclic ring
- membered heterocyclic
- ring containing
- imidazoylalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96575497A | 1997-11-07 | 1997-11-07 | |
PCT/US1998/023224 WO1999024421A1 (en) | 1997-11-07 | 1998-11-05 | Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
Publications (1)
Publication Number | Publication Date |
---|---|
IL135727A0 true IL135727A0 (en) | 2001-05-20 |
Family
ID=25510440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13572798A IL135727A0 (en) | 1997-11-07 | 1998-11-05 | Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1028956A1 (xx) |
JP (1) | JP2001522845A (xx) |
KR (1) | KR20010031839A (xx) |
CN (1) | CN1285828A (xx) |
AR (1) | AR016671A1 (xx) |
AU (1) | AU1296799A (xx) |
CA (1) | CA2309609A1 (xx) |
HU (1) | HUP0102662A3 (xx) |
IL (1) | IL135727A0 (xx) |
PE (1) | PE130699A1 (xx) |
WO (1) | WO1999024421A1 (xx) |
ZA (1) | ZA9810186B (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6140337A (en) * | 1997-12-23 | 2000-10-31 | Schering Corporation | Methods for the treatment of mental disorders |
FR2827863A1 (fr) * | 2001-07-27 | 2003-01-31 | Sanofi Synthelabo | Derives d'aminoalkylimidazole, leur preparation et leur utilisation en therapeutique |
US7183305B2 (en) | 2003-11-11 | 2007-02-27 | Allergan, Inc. | Process for the synthesis of imidazoles |
US7880017B2 (en) | 2003-11-11 | 2011-02-01 | Allergan, Inc. | Process for the synthesis of imidazoles |
WO2005058823A1 (ja) * | 2003-12-17 | 2005-06-30 | Takeda Pharmaceutical Company Limited | ウレア誘導体、その製造法及び用途 |
KR101287955B1 (ko) * | 2004-12-30 | 2013-07-23 | 얀센 파마슈티카 엔.브이. | 지방산 아미드 하이드롤라제의 조정자로서 피페라지닐 및피페리디닐 우레아 |
UA108233C2 (uk) | 2010-05-03 | 2015-04-10 | Модулятори активності гідролази амідів жирних кислот | |
WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
WO2022175384A1 (en) * | 2021-02-17 | 2022-08-25 | Fundación Universidad Católica De Valencia San Vicente Mártir | Small-molecule agents with antiviral activity against rna viruses |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW268950B (xx) * | 1991-12-18 | 1996-01-21 | Schering Corp | |
DK0619818T3 (da) * | 1991-12-18 | 1996-11-25 | Schering Corp | Imidazoylalkyl substitueret med en seks-leddet nitrogenholdig heterocyclisk ring |
AU7823894A (en) * | 1993-08-27 | 1995-03-21 | Vrije Universiteit | New imidazole derivatives having agonistic or antagonistic activity on the histamine h3 receptor |
PE100298A1 (es) * | 1996-08-16 | 1999-01-11 | Schering Corp | Tratamiento de las respuestas alergicas de la vias respiratorias superiores |
-
1998
- 1998-11-05 WO PCT/US1998/023224 patent/WO1999024421A1/en not_active Application Discontinuation
- 1998-11-05 HU HU0102662A patent/HUP0102662A3/hu unknown
- 1998-11-05 CN CN98812984A patent/CN1285828A/zh active Pending
- 1998-11-05 IL IL13572798A patent/IL135727A0/xx unknown
- 1998-11-05 EP EP98956443A patent/EP1028956A1/en not_active Withdrawn
- 1998-11-05 CA CA002309609A patent/CA2309609A1/en not_active Abandoned
- 1998-11-05 JP JP2000520435A patent/JP2001522845A/ja not_active Withdrawn
- 1998-11-05 AU AU12967/99A patent/AU1296799A/en not_active Abandoned
- 1998-11-05 KR KR1020007004911A patent/KR20010031839A/ko not_active Application Discontinuation
- 1998-11-06 PE PE1998001072A patent/PE130699A1/es not_active Application Discontinuation
- 1998-11-06 ZA ZA9810186A patent/ZA9810186B/xx unknown
- 1998-11-06 AR ARP980105620A patent/AR016671A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0102662A3 (en) | 2003-01-28 |
JP2001522845A (ja) | 2001-11-20 |
WO1999024421A1 (en) | 1999-05-20 |
PE130699A1 (es) | 1999-12-16 |
HUP0102662A2 (hu) | 2001-12-28 |
CN1285828A (zh) | 2001-02-28 |
AU1296799A (en) | 1999-05-31 |
EP1028956A1 (en) | 2000-08-23 |
ZA9810186B (en) | 1999-05-06 |
CA2309609A1 (en) | 1999-05-20 |
KR20010031839A (ko) | 2001-04-16 |
AR016671A1 (es) | 2001-07-25 |
WO1999024421A8 (en) | 1999-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0616913A3 (en) | High-temperature battery. | |
HK1032005A1 (en) | Polymeric derivatives of camptothecins. | |
GR3029455T3 (en) | 3-Aryl-4-hydroxy-3-dihydrofuranone derivatives. | |
HRP980043B1 (en) | 8-substituted-1,3,8-triazaspiro/4,5/ decan-4-on derivatives | |
HUT68843A (en) | Urea derivatives | |
GB9313020D0 (en) | Jitter monitoring | |
GB9309716D0 (en) | Heterocyclic derivatives | |
ZA941137B (en) | Substitutet azolone derivatives. | |
ZA9811128B (en) | 1,3,8-Triaza-spiro(4,5)decan-4-on derivatives | |
GB9409948D0 (en) | Dibber drills | |
HU9401766D0 (en) | Urea derivatives containing heterocyclic ring | |
IL109451A0 (en) | Heterocyclic derivatives | |
HUP0102662A3 (en) | Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom | |
EP0710107A4 (en) | DERIVATIVES OF N, N, N-TRIMETHYLSPHINGOSINE | |
AU7596894A (en) | Toothbrush, particularly for one time use | |
EP0605988A3 (en) | A support element. | |
HU9403465D0 (en) | Heterocyclic derivatives | |
ZA948211B (en) | Cyclic amine derivatives | |
FI925634A0 (fi) | Upphettbar vals, i synnerhet en vals foer pappersmaskin | |
EP0783488A4 (en) | FIVE-ELEMENT HETEROCYCLIC COMPOUNDS | |
ZA936048B (en) | Novel 3-oxadiazolyl-1,6-napthyridine derivatives | |
ZA945728B (en) | 7-amino-1,1-dioxocefem l-valylamides | |
HUT71607A (en) | N,n-substituted amino-methylen-imidazolinone derivatives | |
ZA941763B (en) | Carpaine derivatives. | |
ZA926417B (en) | New heterocyclic derivatives. |